APD125 - Therapy for Insomnia

 

Key Data:

Drug (brand/generic)
APD125
Company/licensee
Arena Pharmaceuticals
Therapy class
Serotonin antagonist
Product description
Antagonist of the 5-HT2A receptor
Current indication
Treatment of insomnia
Market sector
CNS
Development status
Phase II

Return to Project



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development